MRTX - Massive Insider Trade At Mirati Therapeutics | Benzinga
Jamie Christensen, EVP & Chief Scientific Officer at Mirati Therapeutics (NASDAQ:MRTX), reported a large insider sell on September 12, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Christensen sold 2,388 shares of Mirati Therapeutics. The total transaction amounted to $85,084.
Mirati Therapeutics shares are trading up 0.19% at $35.2 at the time of this writing on Wednesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used ...